Patents Assigned to Deciphera Pharmaceuticals LLC
  • Anti-inflammatory medicaments
    Patent number: 7144911
    Abstract: Novel compounds and methods of using those compounds for the treatment of inflammatory conditions are provided. In a preferred embodiment, modulation of the activation state of p38 kinase protein comprises the step of contacting the kinase protein with the novel compounds.
    Type: Grant
    Filed: December 24, 2003
    Date of Patent: December 5, 2006
    Assignee: Deciphera Pharmaceuticals LLC
    Inventors: Daniel L. Flynn, Peter A. Petillo